Open AccessMeasuring Disturbance of the Endocannabinoid System in Psychosis
Author(s) -
Amedeo Minichino,
Morwenna Senior,
Natascia Brondino,
Sam H. Zhang,
Beata R. Godlewska,
Philip W. J. Burnet,
Andrea Cipriani,
Belinda Lennox
Publication year - 2019
Publication title -
jama psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.531
H-Index - 365
eISSN - 2168-6238
pISSN - 2168-622X
DOI - 10.1001/jamapsychiatry.2019.0970
Subject(s) - endocannabinoid system , psychosis , disturbance (geology) , psychiatry , psychology , medicine , neuroscience , biology , receptor , paleontology
The endocannabinoid system (ECS) is a lipid-based endogenous signaling system. Its relevance to psychosis is through the association between cannabis use and the onset and course of illness and through the antipsychotic properties of cannabidiol, a potential ECS enhancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom